Published in Nucleic Acids Res on July 25, 1995
Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol (1997) 2.42
The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol (1996) 1.74
Expression and maturation of human foamy virus Gag precursor polypeptides. J Virol (1997) 1.33
Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles. J Virol (1999) 1.18
The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene. J Virol (1996) 0.97
Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases. Retrovirology (2010) 0.95
AZT-resistant foamy virus. Virology (2007) 0.83
Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol (1990) 61.47
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
The retroviral enzymes. Annu Rev Biochem (1994) 4.21
Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat New Biol (1971) 3.95
Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science (1992) 3.81
Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proc Natl Acad Sci U S A (1988) 3.02
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology (1991) 2.70
Identification and characterization of HIV-specific RNase H by monoclonal antibody. EMBO J (1988) 2.56
HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity. EMBO J (1990) 2.54
Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc Natl Acad Sci U S A (1993) 2.30
Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNase H is essentially regarded as an endonuclease. J Biol Chem (1989) 1.82
Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled. J Biol Chem (1991) 1.74
Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase. J Mol Biol (1994) 1.64
Replication and regulation of primate foamy viruses. Virology (1991) 1.57
Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities. J Biol Chem (1993) 1.54
Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1992) 1.48
RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template. Proc Natl Acad Sci U S A (1993) 1.41
Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus. J Virol (1993) 1.33
Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain. J Virol (1993) 1.19
Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases. Nucleic Acids Res (1992) 1.08
Redesignation of the RNase D activity associated with retroviral reverse transcriptase as RNase H. J Virol (1994) 0.99
Sensitive detection of low levels of ribonuclease H activity by an improved renaturation gel assay. Biochem Biophys Res Commun (1993) 0.92
Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol (1988) 3.28
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology (1991) 2.70
Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol (1991) 2.51
Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc Natl Acad Sci U S A (1993) 2.30
Characterization of the transcriptional trans activator of human foamy retrovirus. J Virol (1991) 2.12
False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant. J Thromb Haemost (2010) 1.98
Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol (1995) 1.81
The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol (1996) 1.74
Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses. Nucleic Acids Res (1988) 1.71
Nucleotides at the RNA-DNA covalent bonds formed in the endogenous reaction by the avian myeloblastosis virus DNA polymerase. Virology (1972) 1.58
Comparison of some reactions catalyzed by deoxyribonucleic acid polymerase from avian myeloblastosis virus, Escherichia coli, and Micrococcus luteus. Biochemistry (1972) 1.58
Molecular cloning of the genome of human spumaretrovirus. Gene (1987) 1.52
Analysis of Mycoplasma hyorhinis genome by use of restriction endonucleases and by electron microscopy. J Bacteriol (1982) 1.48
Transferable resistance factors with mutator effect in Salmonella typhi. Mutat Res (1967) 1.46
A survey of heparin monitoring in Australasia. Pathology (1996) 1.38
Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J Virol (1996) 1.35
The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection. J Virol (1994) 1.34
Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus. J Virol (1993) 1.33
Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J Virol (1997) 1.32
RNA-DNA covalent bonds between the RNA primers and the DNA products formed by RNA tumor virus DNA polymerase. J Virol (1973) 1.30
The 3'-orf protein of human immunodeficiency virus 2 shows sequence homology with the bel3 gene of the human spumaretrovirus. FEBS Lett (1987) 1.29
Activation of transcription by guanosine 5'-diphosphate,3'-diphosphate, transfer ribonucleic acid, and novel protein from Escherichia coli. J Biol Chem (1975) 1.27
The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology (1998) 1.26
Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol (2001) 1.24
Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. J Virol (1998) 1.24
The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology (1995) 1.23
Nucleotide sequence analysis of a cloned DNA fragment from human cells reveals homology to retrotransposons. Mol Cell Biol (1987) 1.18
Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains. Virology (1995) 1.18
The intact retroviral Env glycoprotein of human foamy virus is a trimer. J Virol (2000) 1.13
The plaque-forming factor for mink lung cells present in cytomegalovirus and herpes-zoster virus stocks identified as Mycoplasma hyorhinis. J Gen Virol (1981) 1.11
Genomic organization of the human spumaretrovirus and its relatedness to AIDS and other retroviruses. AIDS Res Hum Retroviruses (1988) 1.11
Human T-cell leukemia virus type II Rex binding and activity require an intact splice donor site and a specific RNA secondary structure. J Virol (1991) 1.03
Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease. Biochem Biophys Res Commun (1997) 1.02
Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. EMBO J (1990) 1.02
Analysis of the genome of fish lymphocystis disease virus isolated directly from epidermal tumours of pleuronectes. Virology (1983) 1.02
Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1. J Biol Chem (1995) 1.00
The effect of catabolite repression and of cyclic 3',5' adenosine monophosphate on the translation of the lactose messenger RNA in Escherichia coli. Biochem Biophys Res Commun (1970) 1.00
Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus. J Virol (1999) 0.99
The bet gene of feline foamy virus is required for virus replication. Virology (2001) 0.98
Induction of cellular genes is mediated by the Bel1 transactivator in foamy virus-infected human cells. J Virol (2000) 0.97
Rapid quantitation of interferon with chronically oncornavirus-producing cells. Infect Immun (1976) 0.96
Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology (2001) 0.96
Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences. Virology (2000) 0.95
Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis. Nucleic Acids Res (1993) 0.95
Bacterial expression of the capsid antigen domain and identification of native gag proteins in spumavirus-infected cells. Virus Res (1992) 0.95
Adsorption, penetration, and uncoating of murine leukemia virus studied by using its reverse transcriptase. J Virol (1979) 0.95
Detection by immunofluorescence assay of Bartonella henselae in lymph nodes from patients with cat scratch disease. Clin Diagn Lab Immunol (2003) 0.94
Detection of subgenomic cDNAs and mapping of feline foamy virus mRNAs reveals complex patterns of transcription. Virology (1998) 0.93
Protein kinase and specific phosphate acceptor proteins associated with tupaia herpesvirus. J Virol (1982) 0.93
An effect of interferon on the uncoating of murine leukaemia virus not related to the antiviral state. J Gen Virol (1980) 0.93
DNA analysis of insect iridescent virus 6: evidence for circular permutation and terminal redundancy. J Virol (1984) 0.93
Specific enzyme-linked immunosorbent assay for the detection of antibodies to the human spumavirus. J Virol Methods (1990) 0.93
Molecular cloning and physical mapping of the tupaia herpesvirus genome. J Virol (1985) 0.91
Effect of interferon on mouse cells chronically infected with murine leukaemia virus: kinetic studies on virus production and virus RNA synthesis. J Gen Virol (1978) 0.91
The effect of anaerobiosis and uncouplers on the stimulation of -galactosidase synthesis by cyclic 3',5'-adenosine monophosphate in Escherichia coli. J Gen Microbiol (1972) 0.90
Effect of interferon on exogenous murine leukemia virus infection. Virology (1978) 0.90
Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus. Virology (2000) 0.90
Morphometric and molecular differentiation of Phlebotomus (Phlebotomus) sandflies. Med Vet Entomol (2010) 0.90
Isolation and characterization of DNA-DNA and DNA-RNA. Biochemistry (1977) 0.90
Viral genome RNA serves as messenger early in the infectious cycle of murine leukemia virus. J Virol (1979) 0.89
Detection and molecular characterisation of feline foamy virus serotypes in naturally infected cats. Virology (1998) 0.89
Nuclear localization of the functional Bel 1 transactivator but not of the gag proteins of the feline foamy virus. Virology (1998) 0.89
Molecular cloning and physical mapping of the genome of fish lymphocystis disease virus. Virology (1985) 0.88
Stimulation of lac transcription by guanosine 5'-diphosphate 2'(or 3')-diphosphate and transfer ribonucleic acid. J Biol Chem (1973) 0.88
Cyclic 3';5' adenosine monophosphate-phosphodiesterase and the release of catabolite repression of beta-galactosidase by exogenous cyclic 3';5' adenosine monophosphate in Escherichia coli. Biochem Biophys Res Commun (1971) 0.88
Thymic hormonal activity on human peripheral blood lymphocytes in vitro. II. Enhancement of the production of immune interferon by activated cells. J Immunol (1980) 0.88
An adenovirus from Tupaia (tree shrew): growth of the virus, characterization of viral DNA, and transforming ability. Virology (1980) 0.88
Methylation pattern of fish lymphocystis disease virus DNA. J Virol (1985) 0.87
The mechanism of ultraviolet induction in lysogenic Staphylococcus aureus. J Gen Virol (1968) 0.86
Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon. J Virol (1981) 0.86
Inhibition of retrovirus DNA supercoiling in interferon-treated cells. J Virol (1983) 0.86
Isolation and characterization of a tupaia rhabdovirus. Intervirology (1986) 0.86
Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus. J Virol (1983) 0.85
Malignant tumours in Tupaia (tree shrew). J Med Primatol (1981) 0.85
Relationship between human T cell leukemia virus-II and atypical hairy cell leukemia: a serologic study of hairy cell leukemia patients. Leukemia (1987) 0.85
Rapid purification of extracellular and intracellular Moloney murine leukemia virus. Arch Virol (1982) 0.85
Physical map of tupaia adenovirus DNA by cleavage with restriction endonucleases and partial denaturation. J Gen Virol (1980) 0.84
Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus. J Virol (1980) 0.84
Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I-infected T-cells from apoptosis by the viral tax protein. Exp Cell Res (2001) 0.84
Regulation of gene expression by human foamy virus and potentials of foamy viral vectors. Stem Cells (1997) 0.84
DNA binding properties of the zinc-bound and zinc-free HIV nucleocapsid protein: supercoiled DNA unwinding and DNA-protein cleavable complex formation. FEBS Lett (1995) 0.83
Formation of lipid-nucleotide complex by RNA tumor virus preparations. J Virol (1973) 0.83
Analysis of polypeptides of the tree shrew (Tupaia) herpesvirus by gel electrophoresis. J Gen Virol (1982) 0.83
A rapid streptavidin-capture ELISA specific for the detection of antibodies to feline foamy virus. J Immunol Methods (1997) 0.83
Evidence that protein kinase A activity is required for the basal and tax-stimulated transcriptional activity of human T-cell leukemia virus type-I long terminal repeat. FEBS Lett (1998) 0.83
Evidence for superantigen activity of the Bel 3 protein of the human foamy virus. J Med Virol (1994) 0.82
Cytoplasmic viral DNA synthesis in exogenous infection of murine leukemia virus: effect of interferon and cycloheximide. J Virol (1981) 0.82
A colony assay for in vitro transformation by human T cell leukemia viruses type I and type II. Blood (1987) 0.82
Expression of c-myc and c-ras oncogenes in the neoplastic and non-neoplastic cells of Hodgkin's disease. Eur J Haematol (1995) 0.82
The nucleotide sequence of the inverted terminal repetition of the tree shrew adenovirus DNA. Gene (1983) 0.81
The nucleotide sequence of the early region of the Tupaia adenovirus DNA corresponding to the oncogenic region E1b of human adenovirus 7. Gene (1985) 0.81
Deletion analysis of both the long terminal repeat and the internal promoters of the human foamy virus. Virus Genes (1997) 0.81